Proton Pump Inhibitors
Proton Pump Inhibitors May Increase the Risk of Developing Allergies
Proton pump inhibitors (PPIs) are some of the most widely used medications in the United States and throughout the world. Although drugs like Prevacid, Prilosec, and Nexium have proven helpful to individuals with indigestion and peptic ulcers, they can also have some dangerous side effects. A recent study published in the Nature Communications journal found… read more
Read MorePPI Use in Infants Can Increase the Risk of Fractures, Study Finds
Proton pump inhibitors (PPIs) are some of the most widely prescribed and purchased medications in the world. You might think that heartburn drugs are only used to treat adults. However, PPIs have gained popularity with pediatricians. Many infants are given PPIs to treat gastroesophageal reflux conditions. There are obvious risks for adults who take a… read more
Read MoreProton Pump Inhibitors May Cause Pneumonia in Elderly Patients
For decades, studies have shown that long-term use of proton pump inhibitors is associated with an increased risk of kidney injuries. Thousands of PPI users have filed lawsuits against drug companies for failing to warn them about the risk. They argue that they could have opted for a different heartburn medication if they knew PPIs… read more
Read MoreStudy Reveals Increased Risk of Gynecomastia in Men Who Take a PPI
For decades, proton pump inhibitors (PPIs) have been linked to a host of health issues, including acute and chronic kidney injuries. The list of adverse health events associated with PPIs continues to grow. A new study suggests that the popular class of heartburn medications can also increase the risk of gynecomastia in men. Thousands of… read more
Read MoreProton Pump Inhibitors Could Make It Harder To Treat GI Cancers, New Study Shows
Recently, we reported on troubling research that found a link between proton pump inhibitor drugs, the world’s most popular medications for heartburn, and gastrointestinal cancer. In a wide-ranging study of nearly 63,500 patients, a group of physicians from the University of Hong Kong concluded that, for those patients who received a proton pump inhibitor as… read more
Read MoreHong Kong Researchers Find Higher Risk Of Gastrointestinal Cancer In PPI Patients
Long-term proton pump inhibitor use has been associated with an increased risk for gastrointestinal cancer, according to a new study from researchers at the University of Hong Kong. Analyzing data from nearly 63,400 patients, the study’s authors found a 2.44 increased risk for gastric cancer among patients who had taken one of the popular heartburn… read more
Read More
Recent Comments